Literature DB >> 35591897

Congenital segmental tibial dysplasia and late onset pseudarthrosis of the tibia.

Mahmoud Abdel-Monem El-Rosasy1, Mostafa Elsebai Hammad2, Abdullah Ahmed Nada2.   

Abstract

Background: Congenital pseudarthrosis of the tibia represents a continuum of dysplasia. Most cases develop pseudarthrosis during the first two years of life. Only a few cases with tibial dysplasia present after the age of two years, with or without pseudarthrosis. This under-reported form of Congenital segmental Tibial Dysplasia (CSTD) was investigated to evaluate its distinctive features and possibly predict the disease progression.
Methods: Of the 46 cases presented to our institute over a 20-year period, 17 patients had CSTD. 13 patients developed pseudarthrosis after the age of two years, the average follow up period was four years. Four patients did not break their tibiae until the time of last follow up. Radiological criteria were evaluated by plain x-rays.
Results: According to the radiological criteria, late-presenting CSTD was divided into resolving CSTD (R-CSTD), and pre-pseudarthrosis-CSTD (P-CSTD). In all cases of the R-CSTD group, the tibia had a canalized medullary cavity with anterolateral bowing and segmental cortical sclerosis. While in the P-CSTD group, there was anterolateral bowing, segmental cortical sclerosis, and any of the following: 1) medullary obliteration, 2) cystic changes, 3) hour-glass appearance, 4) Impending fracture, and 5) progressive deformity.
Conclusion: A simple classification of prognostic value has been proposed for cases that did not sustain a fracture until after the age of two years. This differentiation would assist in decision making, and in preoperative counseling for patients. Level of evidence: IV, Retrospective case series.
© 2022 Published by Elsevier B.V. on behalf of Professor P K Surendran Memorial Education Foundation.

Entities:  

Keywords:  Congenital pseudarthrosis of the tibia; Congenital segmental tibial dysplasia; Late onset

Year:  2022        PMID: 35591897      PMCID: PMC9111895          DOI: 10.1016/j.jor.2022.05.004

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  16 in total

Review 1.  Congenital pseudarthrosis of the tibia.

Authors:  S Pannier
Journal:  Orthop Traumatol Surg Res       Date:  2011-10-12       Impact factor: 2.256

2.  Pseudarthrosis of the tibia in childhood.

Authors:  B McFARLAND
Journal:  J Bone Joint Surg Br       Date:  1951-02

3.  Gait analysis and muscle strength in children with congenital pseudarthrosis of the tibia: the effect of treatment.

Authors:  L A Karol; N F Haideri; S E Halliday; T B Smitherman; C E Johnston
Journal:  J Pediatr Orthop       Date:  1998 May-Jun       Impact factor: 2.324

4.  Radiological classification of congenital pseudarthrosis of the tibia.

Authors:  K S Andersen
Journal:  Acta Orthop Scand       Date:  1973

5.  Is late walking a marker of morbidity? Steering Committee, Oxford Region Child Development Project.

Authors:  A Johnson; O Goddard; H Ashurst
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

6.  Pathology and natural history of congenital pseudarthrosis of the tibia.

Authors:  H B Boyd
Journal:  Clin Orthop Relat Res       Date:  1982-06       Impact factor: 4.176

7.  Age for onset of walking and prewalking strategies.

Authors:  Gunfrid V Størvold; K Aarethun; Grete H Bratberg
Journal:  Early Hum Dev       Date:  2013-05-20       Impact factor: 2.079

8.  Distal Tibial Guided Growth for Anterolateral Bowing of the Tibia: Fracture May Be Prevented.

Authors:  Jennifer C Laine; Susan A Novotny; Elizabeth W Weber; Andrew G Georgiadis; Mark T Dahl
Journal:  J Bone Joint Surg Am       Date:  2020-12-02       Impact factor: 5.284

9.  Congenital pseudarthrosis of the tibia: the outcome of a pathology-oriented classification system and treatment protocol.

Authors:  Mahmoud Abdel-Monem El-Rosasy
Journal:  J Pediatr Orthop B       Date:  2020-07       Impact factor: 1.041

10.  Late-onset pseudarthrosis of the dysplastic tibia.

Authors:  J W Roach; R Shindell; N E Green
Journal:  J Bone Joint Surg Am       Date:  1993-11       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.